Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Maximillian J. Wood

68 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: https://openalex.org/A5000306738

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 28 Receptor Pharmacology 22 Pharmacology 21 Clinical Trial 19 Treatment-Resistant Depression 17 Toxicity 13 Mechanism of Action 11 Safety 11 Animal Study 11 Anxiety 10 Chronic Pain 9 Randomized Controlled Trial 8

Journals

bioRxiv 8 Neuroscience Applied 5 Journal of Affective Disorders 3 Chemistry - A European Journal 3 ACS Pharmacology & Translational Science 2 ACS Chemical Neuroscience 2 Psychedelic Medicine 2 Nature 2

Publication history

Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.Clinical toxicology (Philadelphia, Pa.) · 2026-06-22 Structural plasticity and enhanced fear extinction following psilocybin in chronically stressed micebioRxiv · 2026-04-21 The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22 Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical TrialsACS Pharmacology & Translational Science · 2026-03-02 Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-02 The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trialNeuroscience Applied · 2025-12-31 Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic ResearchPsychedelic Medicine · 2025-12-18 Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto RatsPsychedelic Medicine · 2025-12-15 Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Unknown journal · 2025-10-09 Publisher Correction: Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.Nature · 2025-09-30 Beyond prohibition: A public health analysis of naturalistic psychedelic useJournal of Psychedelic Studies · 2025-07-02 Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-06-30 In Vitro Psilocybin Synthesis by Co-Immobilized EnzymesChemistry - A European Journal · 2025-04-08 Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptorsNature · 2025-04-01 Psilocybin mushrooms (“Magic Mushrooms”)Organization of Teratology Information Specialists (OTIS), Brentwood (TN) · 2025-03-31 Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02 Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake ratsbioRxiv · 2025-02-05 Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular BiologybioRxiv · 2025-02-05 The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17 Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods studyScientific Reports · 2024-11-20 Pyramidal cell types and 5-HT2A receptors are essential for psilocybin’s lasting drug actionbioRxiv · 2024-11-02 The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depressionJournal of Psychiatric Research · 2024-10-10 Refractory CRPS pain treated with psilocybin: A case reportClinical Case Reports · 2024-08-31 Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expressionbioRxiv · 2024-05-25 Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptorsbioRxiv · 2024-05-05 At the Forefront: Social Workers’ Role in Psilocybin Treatment for Depression and Substance MisuseSocial Work · 2024-05-01 Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry.Unknown journal · 2024-02-29 Psychedelic-like Activity of Norpsilocin AnaloguesACS Chemical Neuroscience · 2024-01-07 Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS)Journal of Forensic Sciences · 2023-12-21 Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant DepressionUnknown journal · 2023-07-18 Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medicationNeuropsychopharmacology · 2023-07-12 Characterization of Novel Tryptamines’ Anxiolytic and Anti-Inflammatory Effects in Relation to their Psychoactive EffectsJournal of Pharmacology and Experimental Therapeutics · 2023-05-17 Unblinding and demand characteristics in the treatment of depression.Journal of affective disorders · 2023-04-30 Psychedelic Sensationalism: An Analysis of the Schedule Classification of PsilocybinVanderbilt Undergraduate Research Journal · 2023-04-23 Psychotherapy with Psilocybin for Depression: Systematic Review.Unknown journal · 2023-03-30 Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?Clinical Chemistry · 2023-03-06 Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02 The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up studyNeuroscience Applied · 2022-12-31 Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-12-31 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in micebioRxiv · 2022-11-02 Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.ACS Pharmacology & Translational Science · 2022-11-01 Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16 Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examplesActa Crystallographica Section A Foundations and Advances · 2022-07-28 Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related Tryptamines.ChemBioChem · 2022-05-17 Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.NeuroImage · 2022-04-24 Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).ACS Omega · 2022-02-06 The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03 The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31 The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31 Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.Acta Crystallographica Section C Structural Chemistry · 2021-12-31 Structure Elucidation and Spectroscopic Analysis of Chromophores Produced by Oxidative Psilocin Dimerization.Chemistry - A European Journal · 2021-07-05 Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity.Journal of Natural Products · 2021-03-04 Taking Different Roads: l-Tryptophan as the Origin of Psilocybe Natural Products.Unknown journal · 2020-11-24 Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of PsilocybinACS Omega · 2020-06-30 Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortexbioRxiv · 2020-05-02 Scalable Hybrid Synthetic/Biocatalytic Route to PsilocybinChemistry - A European Journal · 2020-02-25 Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and AeruginascinJournal of Natural Products · 2020-02-19 An Improved, Practical, and Scalable Five-Step Synthesis of PsilocybinSynthesis · 2020-01-07 Enzymatic Route toward 6-Methylated Baeocystin and PsilocybinChemBioChem · 2019-05-30 Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.Expert review of clinical pharmacology · 2017-12-31 Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.Unknown journal · 2007-09-30 Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys.Unknown journal · 2004-02-29 Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, U.S.A.Unknown journal · 1982-04-30 Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis (Earle) Singer.Unknown journal · 1982-04-30 Quantitative analysis of psilocybin and psilocin in psilocybe baeocystis (Singer and Smith) by high-performance liquid chromatography and by thin-layer chromatography.Unknown journal · 1981-02-28 Psilocin, bufotenine and serotonin: historical and biosynthetic observations.Unknown journal · 1978-12-31 The effect of bufotenine, melatonin, psilocybin, and related compounds on the 5-hydroxytryptamine excitatory receptors of Helix aspersa neuronsComparative and General Pharmacology · 1972-02-29

Author directory